Computational journey to unveil organophosphorothioate pesticides' metabolism: A focus on chlorpyrifos and CYP2C19 mutational landscape

被引:0
|
作者
Pedroni, Lorenzo
Perugino, Florinda [1 ]
Dall'Asta, Chiara
Galaverna, Gianni
Buratti, Franca Maria
Testai, Emanuela
Dellafiora, Luca [1 ]
机构
[1] Univ Parma, Dept Food & Drug, Parco Area Sci 27-A, I-43124 Parma, Italy
关键词
Molecular modelling; Pesticides; Chlorpyrifos; Cytochrome P450; Polymorphisms; CYTOCHROME-P450; STRUCTURE; FORCE-FIELD; DYNAMICS; SUBSTRATE; INSIGHTS; BINDING; MEPHENYTOIN; EXPOSURE; PROBE; MODE;
D O I
10.1016/j.ecoenv.2024.117354
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Organophosphorothioates (OPT) are pesticides impacting human, animal and environmental health. They enter the environment worldwide, primarily due to their application as insecticides. OPTs are mainly neurotoxic upon bioactivation and inhibition of brain and serum acetylcholinesterase (AChE). Although OPTs are meant to target insects, they are potentially toxic to many other species (including humans), posing risks to non-target organisms and ecosystems. Certain cytochromes P450 (CYP) promote OPTs bioactivation, forming the corresponding oxon metabolites, while others catalyse their detoxification. Understanding the molecular basis of such a bivalent fate may help to clarify the toxicity of OPTs in living organisms, with far-reaching consequences to understand their impact on living organisms and improve risk assessment, to cite but a few. However, although crucial, the underpinning mechanisms still lay unclear. Here, a validated computational pipeline revealed the molecular reasons underlying the differential metabolism of chlorpyrifos in humans by CYP2C19, a primal route of detoxification, and its bioactivation by CYP2B6. The analysis drew the diverse occupancy of the CYP pocket and orientation to the heme group as a convincing evidence-based explanation for the opposite transformation. Moreover, this study explored the impact of CYP2C19 mutational landscape giving a blueprint to unveil the molecular basis of OPTs metabolism and toxicological implications from an inter-individual perspective. Taken together, the outcome described for the first time to the best of our knowledge a structural rationale for the bioactivation/detoxification of OPTs improving the current understanding of their toxicity from a molecular standpoint.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] The role of CYP2C19 in the metabolism of ( plus /-) bufuralol, the prototypic substrate of CYP2D6
    Mankowski, DC
    DRUG METABOLISM AND DISPOSITION, 1999, 27 (09) : 1024 - 1028
  • [32] Functional evaluation of CYP2C19 and CYP3A4 gene polymorphism on ibuprofen metabolism
    Yuan, Ling-Jing
    Li, Xiang-Yu
    Ni, Jin-Huan
    Wang, Jing
    Xu, Xiao-Yu
    Luo, Jian-Chao
    Zhou, Qi
    Hu, Guo-Xin
    Cai, Jian-Ping
    Qian, Jian-Chang
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2023, 475
  • [33] CYP3A4 and CYP2C19 genetic polymorphisms and myricetin interaction on tofacitinib metabolism
    Ye, Zhize
    Xia, Hailun
    Hu, Jinyu
    Liu, Ya-nan
    Wang, Anzhou
    Cai, Jian-ping
    Hu, Guo-xin
    Xu, Ren-ai
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
  • [34] Herbicide metabolism and tolerance in the transgenic rice plants expressing human CYP2C9 and CYP2C19
    Inui, H
    Shiota, N
    Ido, Y
    Inoue, T
    Hirose, S
    Kawahigashi, H
    Ohkawa, Y
    Ohkawa, H
    PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 2001, 71 (03) : 156 - 169
  • [35] The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder
    Uckun, Z.
    Baskak, B.
    Ozel-Kizil, E. T.
    Ozdemir, H.
    Ozguven, H. Devrimci
    Suzen, H. S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (06) : 672 - 679
  • [36] IMPACT OF CYP2C19 GENOTYPES AND EFAVIRENZ ON STEREOSELECTIVE METABOLISM OF OMEPRAZOLE IN HEALTHY VOLUNTEERS
    Michaud, V.
    Ogburn, E. T.
    Kreutz, Y.
    Thong, N.
    Aregbe, A. O.
    Quigg, T. C.
    Epstein, N.
    Callaghan, J. T.
    Flockhart, D. A.
    Desta, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S17 - S17
  • [37] Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH
    Shirai, N
    Furuta, T
    Moriyama, Y
    Okochi, H
    Kobayashi, K
    Takashima, M
    Xiao, F
    Kosuge, K
    Nakagawa, K
    Hanai, H
    Chiba, K
    Ohashi, K
    Ishizaki, T
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (12) : 1929 - 1937
  • [38] Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam
    Contin, M
    Sangiorgi, S
    Riva, R
    Parmeggiani, A
    Albani, F
    Baruzzi, A
    THERAPEUTIC DRUG MONITORING, 2002, 24 (06) : 737 - 741
  • [39] Inhibitory effect of troleandomycin on the metabolism of omeprazole is CYP2C19 genotype-dependent
    He, N
    Huang, SL
    Zhu, RH
    Tan, ZR
    Liu, J
    Zhu, B
    Zhou, HH
    XENOBIOTICA, 2003, 33 (02) : 211 - 221
  • [40] Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype dependent
    V Michaud
    Y Kreutz
    T Skaar
    E Ogburn
    N Thong
    D A Flockhart
    Z Desta
    The Pharmacogenomics Journal, 2014, 14 : 151 - 159